Synthetic short RNA in cancer - Top-Institutions - MDSpire

Synthetic short RNA in cancer

  • By

  • Takeshi Tomita

  • Kentaro Minagawa

  • Sachie Hiratsuka

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Cancer Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Cancer Research

  • #3

    University of Warwick
    University of Warwick

    Coventry, England

    Key Differentiators

    • Computer Science
    • Oncology

  • #4

    University of Nottingham
    University of Nottingham

    Nottingham, England

    Key Differentiators

    • Oncology
    • RNA Therapeutics

  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Cancer Research

Original Source(s)

Synthetic short RNA in cancer

  • by Takeshi Tomita, Kentaro Minagawa, Sachie Hiratsuka

  • May 28, 2026

Related Content

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

FOXA2 in cancer: from fundamental biology to clinical translation

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report